Remote Monitoring in Clinical Trials During the COVID‐19 Pandemic

The coronavirus disease 2019 (COVID‐19) pandemic has rapidly challenged the pharmaceutical industry to implement remote clinical trials. The industry’s lack of extensive experience with remote measurements initiates multiple questions about how to select candidates for remote collection, their valid...

Descripción completa

Detalles Bibliográficos
Autores principales: Izmailova, Elena S., Ellis, Robert, Benko, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307062/
https://www.ncbi.nlm.nih.gov/pubmed/32526077
http://dx.doi.org/10.1111/cts.12834

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307062/
https://www.ncbi.nlm.nih.gov/pubmed/32526077
http://dx.doi.org/10.1111/cts.12834

Ejemplares similares